Moody Aldrich Partners’s West Pharmaceutical WST Stock Holding History

Moody Aldrich Partners’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,146	Closed	-$323K	–	198
2021 Q1	$323K	Buy	1,146 +176	+18%	+$50.4K	0.05%	152
2020 Q4	$275K	Sell	970 -6	-0.6%	-$1.68K	0.04%	152
2020 Q3	$268K	Sell	976 -268	-22%	-$70.9K	0.06%	136
2020 Q2	$283K	Sell	1,244 -533	-30%	-$105K	0.06%	140
2020 Q1	$271K	Sell	1,777 -6	-0.3%	-$924	0.08%	122
2019 Q4	$268K	Buy	+1,783	New	+$260K	0.06%	133
2019 Q3	–	Sell	-2,411	Closed	-$302K	–	141
2019 Q2	$302K	Buy	+2,411	New	+$285K	0.08%	113
2018 Q4	–	Sell	-1,817	Closed	-$224K	–	113
2018 Q3	$224K	Buy	+1,817	New	+$204K	0.06%	98

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Moody Aldrich Partners's WST Position: Q2 2021 in Review

Moody Aldrich Partners sold out of West Pharmaceutical (WST) in Q2 2021, closing a stake of 1,146 shares — an estimated $323K sold.

Moody Aldrich Partners first reported a position in WST in Q3 2018 and held it in 8 quarters. The position peaked at $323K in Q1 2021. 640 funds tracked by Wall St. Rank hold WST as of Q2 2021.

Moody Aldrich Partners reported no remaining West Pharmaceutical position as of Q2 2021 after selling out during the quarter.
Moody Aldrich Partners sold 1,146 West Pharmaceutical shares in Q2 2021, an estimated $323K.
Moody Aldrich Partners first reported a position in West Pharmaceutical in Q3 2018 and held it in 8 quarters.
Moody Aldrich Partners's West Pharmaceutical position peaked at $323K in Q1 2021.
640 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2021.

Based on Moody Aldrich Partners's 13F filing for Q2 2021, filed 4 Aug 2021.